CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results Encouraging

Data ReadoutpositivePositive
AI Analysis

Summary

Jim Cramer commented positively on trial results from Moderna and Merck. The article lacks specific details about the trial, drug, indication, or magnitude of results.

Clinical Trial Data

Importance:5/10
Sentiment:
0.65
clinical trialModernaMercktrial resultspositive data
Related Companies

Read the original article

Published by yahoo_finance on August 31, 2026 5:35 AM

Read Original